2'-deoxyadenosine triphosphate has been researched along with Disease Models, Animal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Arnold, M; Branstrom, A; Chen, G; Cui, C; Drennan, CL; Dumble, M; Gerasyuto, A; Hedrick, J; Jung, SP; Karp, G; Letinski, S; Levitz, T; Narasimhan, J; Ravichandran, K; Stubbe, J; Wang, J | 1 |
Carey, J; Kadota, S; Laflamme, MA; Leggett, J; Mahairas, GG; Murry, CE; Regnier, M; Reinecke, H; Teichman, S | 1 |
Cheng, Y; Hogarth, KA; O'Sullivan, ML; Pyle, WG; Regnier, M | 1 |
Blackburn, MR; Joachims, ML; Laurent, AB; Marble, PA; Paliotta, M; Pastuszko, P; Thompson, LF | 1 |
Henderson, JF; Smith, CM | 1 |
Begleiter, A; Dean, HJ; Johnston, JB; Kobrinsky, NL; Thliveris, JA; Verburg, L | 1 |
Aldrich, M; Blackburn, MR; Chen, W; Datta, SK; Hershfield, MS; Kellems, RE; Kelly, S; Volmer, JB; Zhong, H | 1 |
7 other study(ies) available for 2'-deoxyadenosine triphosphate and Disease Models, Animal
Article | Year |
---|---|
Ribonucleotide reductase, a novel drug target for gonorrhea.
Topics: Allosteric Regulation; Animals; Anti-Bacterial Agents; Deoxyadenine Nucleotides; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Female; Gonorrhea; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pyridines; Ribonucleotide Reductases | 2022 |
Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure.
Topics: Animals; Blood Pressure; Chronic Disease; Deoxyadenine Nucleotides; Dependovirus; Disease Models, Animal; Echocardiography; Genetic Therapy; Genetic Vectors; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Ribonucleotide Reductases; Swine; Swine, Miniature; Systole | 2015 |
2-Deoxyadenosine triphosphate restores the contractile function of cardiac myofibril from adult dogs with naturally occurring dilated cardiomyopathy.
Topics: Actomyosin; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Deoxyadenine Nucleotides; Disease Models, Animal; Dogs; Energy Metabolism; Female; Kinetics; Male; Myocardial Contraction; Myofibrils; Myosins; Phosphorylation; Recovery of Function | 2016 |
Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases.
Topics: Adenosine Deaminase; Animals; Apoptosis; Cell Culture Techniques; Cell Differentiation; Coculture Techniques; Deoxyadenine Nucleotides; Disease Models, Animal; Enzyme Inhibitors; Fetus; Humans; Mice; Phosphotransferases (Alcohol Group Acceptor); Severe Combined Immunodeficiency; Thymus Gland | 2008 |
Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Coformycin; Deoxyadenine Nucleotides; Disease Models, Animal; Erythrocytes; Mice; Nucleoside Deaminases; Pentostatin; Ribonucleosides | 1982 |
Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.
Topics: Adenosine Deaminase Inhibitors; Animals; Deoxyadenine Nucleotides; Diabetes Mellitus, Type 1; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Organ Size; Pentostatin; Rats; Rats, Inbred BB; Spleen; Thymus Gland | 1993 |
The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities.
Topics: Adenosine; Adenosine Deaminase; Adenosylhomocysteinase; Animals; Deoxyadenine Nucleotides; Deoxyadenosines; Disease Models, Animal; Genotype; Histocytochemistry; Hydrolases; Killer Cells, Natural; Lung; Lymphocyte Count; Lymphocytes; Lymphopenia; Mice; Mice, Transgenic; Phenotype; S-Adenosylhomocysteine; Severe Combined Immunodeficiency; Spleen; Thymus Gland | 2000 |